Navigation Links
Former Patent Office Solicitor and Judge Joins Rothwell Figg
Date:1/10/2008

Nancy Linck Extends Firm's Life Sciences Capabilities

WASHINGTON, Jan. 10 /PRNewswire/ -- Rothwell, Figg, Ernst & Manbeck, P.C. announced today that Dr. Nancy J. Linck will join the firm in an Of Counsel position, effective Feb. 4, 2008. Dr. Linck has served as the former Solicitor and later an Administrative Patent Judge at the U.S. Patent & Trademark Office (USPTO), former Deputy General Counsel, IP & Trade, for the Biotechnology Industry Organization (BIO), and Senior Vice President, Intellectual Property and Regulatory Affairs and Chief Compliance Counsel, for Guilford Pharmaceuticals.

Dr. Linck commented that, "Rothwell, Figg, Ernst & Manbeck will provide an exceptional environment for me to return to private practice, and I am delighted to join what I have long regarded as one of the nation's leading intellectual property law firms."

"Rothwell Figg has, over many years, developed a strong biotechnology and pharmaceutical practice, and Nancy's extensive intellectual property expertise in these fields will help us expand our reach and continue to offer excellent service to our clients in these industries," Tony Figg of Rothwell, Figg, Ernst & Manbeck, P.C. said. "Nancy is one of the country's top IP lawyers, and her experience in private and corporate practice, as a frequent advocate for the USPTO in the Federal Circuit, and as a member of the Board of Patent Appeals and Interferences puts her in an extraordinary position to represent and counsel clients in a wide range of capacities."

The addition of Dr. Linck to the Rothwell Figg team is particularly timely in light of upcoming changes in the pharmaceutical and biotechnology markets. An estimated $29 billion worth of pharmaceutical patents are set to expire in the next two years, which will likely result in an increase in patent disputes as companies attempt to protect or extend their patents. Rothwell Figg will be well-positioned to advise companies on these matters.

Before becoming Solicitor at the USPTO, Nancy was a partner at Cushman, Darby & Cushman. In addition, Dr. Linck has corporate experience working both as a patent attorney for Monsanto and a chemist at Dow Chemical Company.

Other legal experience includes training as a mediator in the Federal Circuit's Pilot Mediation Program, serving as a consultant and expert witness in numerous patent cases in federal courts and in the FTC, and teaching law at both the Georgetown University Law Center and George Washington University School of Law.

Dr. Linck received her J.D. from Western New England College School of Law and her Ph.D. and M.S. in Inorganic Chemistry from the University of California, San Diego. She also holds a B.S. in Chemistry from the University of California, Berkeley, and expects to receive an M.S. in Biotechnology from Johns Hopkins University later this year.

Her bar membership includes the U.S. Supreme Court, U.S. Court of Appeals for the Federal Circuit, District of Columbia, U.S. Patent and Trademark Office, and Commonwealth of Massachusetts.

About Rothwell, Figg, Ernst & Manbeck, P.C.

Based in Washington, D.C., Rothwell Figg is one of the nation's top intellectual property law firms. The firm specializes in litigation, counseling, copyright, licensing and transactions, patent prosecution, trade dress, trademarks, and unfair competition. In addition to its patent and trademark prosecution, licensing and intellectual property counseling practices, the firm has handled a large number of complex and high-profile patent litigations before U.S. federal district courts and courts of appeals and the U.S. International Trade Commission, interference actions before the U.S. Patent and Trademark Office, and has argued patent appeals before the U.S. Patent and Trademark Office.


'/>"/>
SOURCE Rothwell, Figg, Ernst & Manbeck, P.C.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
4. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
7. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
8. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
11. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... 2017  VMS BioMarketing, a leading provider of patient support ... Nurse Educator (CNE) network, which will launch this week. The ... health care professionals to enhance the patient care experience by ... other health care professionals to help women who have been ... ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... San Diego-based ... of its corporate rebranding initiative announced today. The bold new look is part ... as the company moves into a significant growth period. , It will also expand ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
(Date:10/9/2017)... ... , ... At its national board meeting in North Carolina, ARCS® Foundation ... of Physics and Astronomy, has been selected for membership in ARCS Alumni Hall ... 2015 Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion of ...
Breaking Biology Technology:
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):